Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.
Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- CheckyesterdayChange DetectedThe Locations section now lists Minnesota as a study site. The Minnesota Locations entry and the HHS Vulnerability Disclosure section were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check30 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, reflecting a metadata version change. This does not modify study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check37 days agoChange DetectedRemoved the temporary funding-status notice banner from the page. Core study information and links remain unchanged.SummaryDifference0.3%
- Check51 days agoChange DetectedResults have been posted for the study, and the record now includes updated study dates, status, and outcome measures. This adds visibility into trial findings and current completion status.SummaryDifference0.3%
- Check80 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.